“…(2008 , 2012 ), included the following: Cyclin A3 ( CYCA3 , HORVU.MOREX.r2.5HG0363660 ; a checkpoint regulator of S, S/G2 transition; Gendreau et al ., 2012 ; Qi and Zhang, 2020 ); Cyclin B1 ( CYCB1 , HORVU.MOREX.r2.3HG0246040 ; a checkpoint regulator at the G2/M transition; Dewitte et al , 2003 ); Cyclin-Dependent Kinase A1 (CDKA1 , HORVU.MOREX.r2.6HG0457700 ; known to be constitutively expressed throughout the cell cycle and acts as a positive regulator of cell proliferation; Iwakawa et al ., 2006 ; Gendreau et al ., 2012 ), Cyclin-Dependent Kinase B1 ( CDKB1 , HORVU.MOREX.r2.7HG0565000 ; functions during G2/M and the S/G2 phase of the cell cycle; Dewitte et al , 2003 ; Gendreau et al ., 2012 ); Cyclin-Dependent Kinase D1 ( CDKD1 , HORVU.MOREX.r2.7HG0565000 ; its expression increases from G1 to S phase, and it mediates cell-cycle progression through the activation of CDK s such as CDKA1 and CDKB1 ; Gendreau et al ., 2012 ; Gutierrez et al , 2009 ; Takatsuka et al ., 2015 ); and the nuclear kinase WEE1 ( HORVU.MOREX.r2.6HG0461230 ; a negative regulator of the G2/M phase that inhibits the activities of CDKA and CDKB ; De Schutter et al , 2007 ; Qi and Zhang, 2020 ). The MYB3R4 transcription factor ( HORVU.MOREX.r2.3HG0206530 ) has not been formally identified as a cell-cycle marker, but it controls the expression of G2/M phase-specific genes and maintains diploidy ( Saito et al , 2015 ; Haga et al , 2007 , 2011 ). For a schematic depiction of the known roles of these genes in the cell cycle, see Fig.…”